We report a novel fusion of the MYST4 and CBP genes in an acute myeloid leukaemia
(AML)‐M4 patient exhibiting t (10; 16)(q22; p13) and t (11; 17)(q23; q21). The t (10; 16)(q22; …

Acute myeloid leukemia (AML) with translocation t (8; 16)(p11; p13) is an infrequent
leukemia subtype with characteristic clinicobiological features. This translocation leads to …

The reciprocal chromosomal rearrangement t (8; 16)(p11; p13) is rare both in adult and
pediatric acute myeloid leukemias (AML) accounting 0.2–0.4% of de novo AML and 6.5% of …

Recently, it was shown that t (10; 16)(q22; p13) fuses the MORF and CREBBP genes in a
case of childhood acute myeloid leukemia (AML) M5a, with a complex karyotype containing …

The translocation t (8; 16)(p11; p13), which results in fusion of the MOZ/MYST3/KAT6A gene
(8p11) and CBP/CREBBP gene (16p13), is characterized by unique morphologic and …

Abstract The t (8; 16)(p11; p13) is a rare translocation involved in de novo and therapy-
related myelomonocytic and monocytic acute leukemia. It fuses two genes encoding histone …

We present a case of acute myeloid leukemia (AML) with a cytogenetically typical inv
(16)(p13q22), M4 morphology and eosinophilia. However, studies revealed a CBFβ-MYH11 …

We report the case of a 2-year-3-month-old boy with acute megakaryoblastic leukemia
showing hemophagocytosis by leukemic blasts. The chromosome analysis of his bone …

Inv (16)(p13. 1q22) in acute myeloid leukemia (AML) is a common chromosomal
abnormality. It leads to the core-binding factor ß-subunit (CBFβ)/smooth muscle myosin …

Pediatric acute myeloid leukemia (AML) is a heterogeneous disease, characterized by
different collaborating karyotypic and molecular abnormalities, which are used in risk group …